Mesothelioma and asbestos-related pleural diseases

被引:35
作者
Greillier, Laurent [1 ]
Astoul, Philippe [1 ]
机构
[1] Univ Mediterranee, Fac Med, Assistance Publ Hop Marseille, Serv Oncol Thorac, Marseille, France
关键词
asbestos; mesothelioma; plaque; pleural effusion; pleural cancer; rounded atelectasis; pleural fibrosis;
D O I
10.1159/000127577
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
At present, the use of asbestos is not regulated at a worldwide scale. Moreover, there is a latency period between asbestos exposure and the manifestations of asbestos-related diseases. Consequently, pulmonologists are still dealing with consequences of asbestos exposure, which mainly occur at the pleural surface. The aim of this review is to provide an overview of asbestos-related pleural diseases. We summarized the most relevant data for the diagnosis and the management of benign asbestos pleural effusions, pleural plaques, diffuse pleural thickening and rounded atelectasis. Special attention is dedicated to malignant pleural mesothelioma, given the challenging issues of this disease, the recent advances in its management and the dynamism of research in this area. Copyright (C) 2008 S. Karger AG, Basel.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 192 条
[71]   Role of DNA microarrays in the diagnosis of pleural exudates: a feasibility study [J].
Greillier, L. ;
Roll, P. ;
Barlesi, F. ;
Robaglia-Schlupp, A. ;
Fraticelli, A. ;
Cau, P. ;
Astoul, P. .
REVUE DES MALADIES RESPIRATOIRES, 2007, 24 (07) :859-867
[72]  
GREILLIER L, 2006, REV MAL RESP, V23
[73]   Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma [J].
Greillier, Laurent ;
Cavailles, Arnaud ;
Fraticelli, Anne ;
Scherpereel, Arnaud ;
Barlesi, Fabrice ;
Tassi, Gianfranco ;
Thomas, Pascal ;
Astoul, Philippe .
CANCER, 2007, 110 (10) :2248-2252
[74]   Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment [J].
Grigoriu, Bogdan-Dragos ;
Scherpereel, Arnaud ;
Devos, Patrick ;
Chahine, Bachar ;
Letourneux, Marc ;
Lebailly, Pierre ;
Gregoire, Marc ;
Porte, Henri ;
Copin, Marie-Christine ;
Lassalle, Philippe .
CLINICAL CANCER RESEARCH, 2007, 13 (10) :2928-2935
[75]  
HARBER P, 1987, J OCCUP ENVIRON MED, V29, P641
[76]  
Hassan R, 2007, J CLIN ONCOL, V25
[77]   Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer [J].
Hassan, R ;
Remaley, AT ;
Sampson, ML ;
Zhang, JL ;
Cox, DD ;
Pingpank, J ;
Alexander, R ;
Willingham, M ;
Pastan, I ;
Onda, M .
CLINICAL CANCER RESEARCH, 2006, 12 (02) :447-453
[78]  
HENNEQUIN C, 2006, REV MAL RESP, V23
[79]   Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B [J].
Herndon, JE ;
Green, MR ;
Chahinian, AP ;
Corson, JM ;
Suzuki, Y ;
Vogelzang, NJ .
CHEST, 1998, 113 (03) :723-731
[80]  
HILLERDAL G, 1980, EUR J RESPIR DIS, V61, P129